Autobio(SH:603658)2021-10-25 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥1,017,639,627.62, representing a year-on-year increase of 20.92%[4] - The net profit attributable to shareholders for the same period was ¥303,895,597.88, reflecting a growth of 26.45% compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥307,327,926.66, which is an increase of 38.18% year-on-year[4] - The basic earnings per share for Q3 2021 was ¥0.52, up by 20.93% year-on-year[5] - The company reported a year-to-date net profit growth of 39.33%, driven by increased revenue and reduced non-recurring losses[9] - The diluted earnings per share for the year-to-date period was ¥1.22, representing a year-on-year increase of 32.61%[5] - Net profit for Q3 2021 was ¥724,329,571.32, representing a 39.3% increase compared to ¥519,954,326.06 in Q3 2020[19] - Earnings per share for Q3 2021 was ¥1.22, compared to ¥0.92 in Q3 2020, reflecting a 32.6% increase[20] Cash Flow - The cash flow from operating activities for the year-to-date period reached ¥933,770,922.23, showing a significant increase of 191.08% compared to the same period last year[4] - The company experienced a significant increase in cash flow due to higher sales collections during the reporting period[9] - Operating cash inflow for the first nine months reached CNY 3,111,829,528.21, a significant increase from CNY 2,127,606,703.00 in the same period last year, reflecting a growth of approximately 46.3%[21] - Net cash flow from operating activities for the first nine months was CNY 933,770,922.23, compared to CNY 320,793,865.61 in the previous year, indicating a growth of about 191.5%[21] - Cash inflow from the sale of goods and services of CNY 2,977,288,864.34 for the first nine months, compared to CNY 1,971,196,231.24 in the same period last year, representing a growth of approximately 50.9%[21] - Cash outflow for operating activities totaled CNY 2,178,058,605.98, an increase from CNY 1,806,812,837.39 in the previous year, reflecting a rise of about 20.5%[21] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥8,831,122,324.15, an increase of 8.53% from the end of the previous year[5] - The total liabilities increased to ¥1,684,041,384.08 in Q3 2021, up from ¥1,551,830,613.40 in Q3 2020, marking an 8.5% rise[17] - The total equity attributable to shareholders reached ¥7,019,028,364.53, an increase of 8.4% from ¥6,477,364,992.31 in the previous year[17] - The company's total assets reached ¥8,831,122,324.15, up from ¥8,137,141,424.06 at the end of 2020[15] - Total current assets increased to ¥5,297,146,962.23 from ¥5,094,706,551.38 year-over-year[15] - Accounts receivable stood at ¥959,548,747.10, slightly up from ¥956,321,567.00 in the previous year[15] - Inventory increased to ¥588,528,054.20 from ¥475,522,514.41 year-over-year[15] - The company reported a significant increase in long-term construction projects, with amounts rising to ¥1,010,494,938.09 from ¥641,796,635.03[15] Shareholder Information - Total number of common shareholders at the end of the reporting period was 43,327[11] - The largest shareholder, Zhengzhou Antu Industrial Group Co., Ltd., holds 323,524,173 shares, accounting for 55.18% of total shares[11] Research and Development - Research and development expenses for the first three quarters of 2021 were ¥337,848,595.48, up from ¥236,095,886.07 in the same period of 2020, indicating a 43.1% increase[18] - The company has no reported new product launches or technological developments in this quarter[13] Mergers and Acquisitions - There are no significant mergers or acquisitions reported during this period[13] Investment Income - The company reported investment income of ¥80,526,152.21 in Q3 2021, compared to ¥38,324,337.79 in Q3 2020, which is a 109.5% increase[19] Tax Liabilities - The deferred income tax liabilities increased to ¥305,336,611.15 in Q3 2021 from ¥236,607,303.92 in Q3 2020, a rise of 29.0%[17]